A recently published article in the American Journal of Public Health has attributed a substantial financial cost to untreated perinatal mood and anxiety disorders among mothers. The study, conducted by researchers with the think [...]
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the practice of reproductive psychiatry amidst the COVID-19 pandemic with Ob.Gyn News on [...]
According to the American College of Obstetricians and Gynecologists, we have limited information regarding COVID-19 during pregnancy; however, in the absence of adequate information, we consider pregnant women to be an at-risk population for [...]
As mental health providers, most of us are not on the front lines of the COVID-19 pandemic; however, we are feeling the ripples. Given the magnitude of this crisis and its significant impact on [...]
Suicidal ideation is relatively common among pregnant women; however, the risk of attempted or completed suicide in this population is low.
ACOG recommends that clinicians screen women at least once during the perinatal period for anxiety symptoms.
At the Center for Women’s Mental Health, it has always been our belief that one of our best tools for combating anxiety is to provide accurate and up-to-date information. There are several sites that provide information about COVID-19.
If sleep disturbance is the harbinger of perinatal anxiety and OCD, it might make sense to place more emphasis on this symptom.
Early pregnancy loss is common, affecting up to 25% of pregnancies. Studies looking at the emotional consequences of miscarriage have shown that...
The US Preventive Services Task Force (USPSTF) unequivocally recommends that ALL WOMEN who are either planning or capable of pregnancy take a DAILY SUPPLEMENT containing 0.4 TO 0.8 mg (400-800 µg) OF FOLIC ACID.  [...]
